Russia expressed readiness to produce a vaccine against Covid-19 on the territory of Algeria, Russian Ambassador to Algeria Igor Belyaev said, highlighting that talks took place on this matter with the Algerian senior officials.
“We have discussed this issue during our meetings with [Algeria’s] health minister and the minister of pharmaceutical industry. Russia is ready to cooperate with Algeria to design a vaccine on the local level, and I mean here the Russian Direct Investment Fund, which deals with the distribution of the vaccine outside the country,” Belyaev said.
“It [the fund] proposes multiple options of engagement, including direct acquisition, transfer of technology, joint production, and participation in the third phase of tests – we have offered all that to the Algerian side,” the ambassador added.
Noting that Russia’s Sputnik V became the world’s first registered vaccine against COVID-19 on 11 August. The vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology, with support from the sovereign wealth fund, and is currently completing phase 3 clinical trials.